Indian pharmaceutical company Dr. Reddy’s Laboratories announced in a recent SEC filing that it is currently being investigated by the Department of Justice for False Claims Act violations in connection with the company’s alleged failure to adequately child-proof its drug packaging. According to the company, U.S. Consumer Product Safety Commission is pursuing civil penalties under the Consumer Product Safety Act and Poison Prevention Packaging Act as a result of Dr. Reddy’s alleged misconduct.
Read FiercePharma Manufacturing’s article, “DOJ investigates Dr. Reddy’s for failing to protect children with packaging”